Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Northside Hospital, Inc.

Clinical trials sponsored by Northside Hospital, Inc., explained in plain language.

Trials to join now! 7 Not yet recruiting 1

New hope for aggressive leukemia: drug trio targets tough genetic mutation

Disease control Not yet recruiting

This early-phase trial tests a new drug called axatilimab combined with two standard chemotherapy drugs for people with a specific, hard-to-treat type of acute myeloid leukemia (AML) that has a TP53 mutation or deletion. The study aims to find the safest dose of axatilimab and se…

Phase: PHASE1 • Sponsor: Northside Hospital, Inc. • Aim: Disease control

Last updated May 26, 2026 08:11 UTC